Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15787131 | 1.00 | PTGS1 (0.31) | PTGS1ALDH1A1 | |
| SCHEMBL3643168 | 1.00 | PTGS1 (0.31) | PTGS1ALDH1A1 | |
| SCHEMBL9700548 | 0.79 | — | — | |
| SCHEMBL572113 | 0.78 | — | — | |
| SCHEMBL572114 | 0.78 | — | — | |
| SCHEMBL18992026 | 0.77 | PTGS1 (0.31) | PTGS1ALDH1A1 | |
| SCHEMBL22616198 | 0.73 | TSHR (0.33) | — | |
| SCHEMBL22616195 | 0.73 | TSHR (0.33) | — | |
| SCHEMBL9912674 | 0.73 | TSHR (0.33) | — | |
| Bicarbonate SCHEMBL28971464 | 0.73 | CA1 (0.46) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224437-A1 | BIOMARKERS FOR LUNG CANCER | ABERYSTWYTH UNIVERSITY (GB) | 2025-10-30 | — | — | WO | claimed |
| US-20250066823-A1 | METHODS FOR ENGINEERING OUTER MEMBRANE VESICLE PRODUCTION AND CARGO PACKAGING IN PSEUDOMONAS PUTIDA | Alliance for Energy Innovation, LLC | 2025-02-27 | — | — | US | claimed |
| US-20160355844-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-12-08 | — | — | US | claimed |
| US-20160355843-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2016-12-08 | — | — | US | claimed |
| CN-104769119-A | Methods for biosynthesizing 1,3 butadiene | INVISTA TECH SARL | 2015-07-08 | — | — | CN | claimed |
| EP-2861745-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | Invista Technologies S.à.r.l. (CH) | 2015-04-22 | — | — | EP | claimed |
| CN-104321434-A | Methods for biosynthesizing 1,3butadiene | INVISTA TECH SARL | 2015-01-28 | — | — | CN | claimed |
| EP-2785848-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA Technologies S.à.r.l. (CH) | 2014-10-08 | — | — | EP | claimed |
| US-20140141482-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA North America S.á r.l. (US) | 2014-05-22 | — | — | US | claimed |
| WO-2013188546-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA TECHNOLOGIES S.À.R.L. (CH) | 2013-12-19 | — | — | WO | claimed |
| US-20130189753-A1 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA NORTH AMERICA S.A R.L. (US) | 2013-07-25 | — | — | US | claimed |
| WO-2013082542-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-06-06 | — | — | WO | claimed |
| US-6548292-B1 | From Pseudomonas; comprises genes encoding enzymes involved in catchol cleavage, mercury tolerance, plasmid stability, and replication | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-04-15 | — | — | US | claimed |
| US-4859592-A | Production of picolinic acid and pyridine products via pseudomonas | CELGENE CORPORATION | 1989-08-22 | — | — | US | claimed |
| US-4673646-A | Production of 2-hydroxymuconic semialdehyde | CELANESE CORPORATION (US) | 1987-06-16 | — | — | US | claimed |
| US-4654303-A | Construction of novel mutant microorganisms | CELANESE CORPORATION (US) | 1987-03-31 | — | — | US | claimed |
| EP-0138391-A1 | Construction of novel mutant micro-organisms | CELGENE CORPORATION (US) | 1985-04-24 | — | — | EP | claimed |
| JP-56124384-A | — | — | None | — | — | JP | disclosed |
| US-4259318-A | LACCASE TOPICALLY APPLIED | UNIVERSITY OF HOUSTON, CENTRAL CAMPUS (US) | 1981-03-31 | — | — | US | disclosed |
| US-4002737-A | Prevention and/or treatment of poison ivy dermatitis | RESEARCH CORPORATION (US) | 1977-01-11 | — | — | US | disclosed |